Position eingeben

Gehaltsübersicht für Head Of Biology in Schweiz

Erhalten Sie Statistikinformationen per E-Mail

Gehaltsübersicht für Head Of Biology in Schweiz

24 000 ₣ Durchschnittliches Monatsgehalt

Durchschnittliches Gehaltsniveau in den letzten 12 Monaten: "Head Of Biology in Schweiz"

Währung: CHF USD Jahr: 2021
Das Balkendiagramm zeigt die Änderung des Gehaltsniveaus in der Head Of Biology Branche in Schweiz

Verteilung des Stellenangebots "Head Of Biology" in Schweiz

Währung: CHF
Wie die Grafik zeigt, in Schweiz gilt Basel-Stadt als die Region mit der größten Zahl der offenen Stellen in und an zweiter Stelle folgt Kanton Bern. Den dritten Platz nimmt Kanton Waadt ein.

Ranking der Kantone in Schweiz gemäß dem Gehaltsniveau für den Beruf "Head Of Biology"

Währung: CHF
Wie die Grafik zeigt, in Schweiz gilt Basel-Stadt als die Region mit der größten Zahl der offenen Stellen in und an zweiter Stelle folgt Kanton Bern. Den dritten Platz nimmt Kanton Waadt ein.

Ranking der ähnlichen Stellenangebote gemäß dem Gehaltsniveau in Schweiz

Währung: CHF
Unter den ähnlichen Berufen in Schweiz gilt Associate als der bestbezahlte Beruf. Laut unserer Webseite beträgt das Durchschnittseinkommen 73115 CHF. An zweiter Stelle folgt Junior Accountant mit dem Gehalt von 72500 CHF und den dritten Platz nimmt Agent mit dem Gehalt von 72000 CHF ein.

Empfohlene Stellenangebote

Bioanalytical Manager
Coopers Group AG, Basel-Stadt
The perfect candidate is someone who has done a similar position in bioanalysis previously within a pharma (preferred) or a CRO or an experienced scientist with experience with small and/or large molecules very keen to learn and with a positive attitude. Please note the preference goes to the first profile (experience in pharma/CRO). In any case, the successful candidate will have an education within biology / biochemistry. On this position, the perfect candidate has strong experience on both small AND large molecules. This is a long-term contract with a potential internal opportunity afterwards.  Tasks & Responsibilities:Lead bioanalytical strategies to generate decision-enabling bioanalytical data with skilled data interpretation to meet and answer project needsResponsible for outsourcing activities in Bioanalytics (bioanalysis of non-clinical and clinical studies); resource and time planning, coordination and administrative management of studies with CROs.Manage the development, transfer and validation of specific and sensitive bioanalytical methods required for the development compound (drug), anti-drug antibodies (ADA), soluble targets and any concomitant/interaction compound in the given project.Manage and direct analysis of samples and timeline from preclinical and clinical studies for the project at CRO labs.Participate actively in PS subteams, act as primary contact person for DMPK project leader.Act as Bioanalytical Leader when required. Interact proactively with the assay development team.Ensure full compliance with the current global and local bioanalytical guidance and GxPs.Leadership in Bioanalysis: *remain current and continually develop expertise in bioanalytical science. Contribute to scientific consortia when required; *maintain current expertise in the validation and conduct of bioanalytical assays; *guide and manage the bioanalysis at CROs and ensure that most advanced and most efficient procedures are used.Provide technical leadership in issue resolution.Review protocols and other relevant documents and guide project teams in all aspects of bioanalytical work required for the project.Review and write reports for regulatory submissions; support filings and answer any questions about bioanalytics coming from the regulatory agencies.Maintain open links with other disciplines within the department and the organization.Advise Group Head concerning all needs relating to administrative processes, technologies and equipment. Inform him of all critical issues Must haves:Minimum 3 years in a similar position focused on bioanalysis in pharma or CRO (pharma preferred) OR scientist focused on bioanalysis Excellent work experience on both large and small molecules bioanalysis Strong vendor management experience, looking after outsourced studies to external CROsDegree in biology/biochemistry  
Bioanalytical Manager
Randstad (Schweiz) AG, Basel
For our client, a pharmaceutical company in the Basel area we are looking for anBioanalytical Manager Start date: middle May 2021, latest August 2021End date:18 monthsExtension: possibleWork location: BaselRemote/Home Office: home office at the momentBackground:This position will be focused on external CRO management. The successful candidate will look after studies done externally from a bioanalytical point of view (e.g measuring blood & tissue concentration in both humans & animals). This will be on both small and large molecules.Tasks & Responsibilities:Lead bioanalytical strategies to generate decision-enabling bioanalytical data with skilled data interpretation to meet and answer project needsResponsible for outsourcing activities in Bioanalytics (bioanalysis of non-clinical and clinical studies); resource and time planning, coordination and administrative management of studies with CROs.Manage the development, transfer and validation of specific and sensitive bioanalytical methods required for the development compound (drug), anti-drug antibodies (ADA), soluble targets and any concomitant/interaction compound in the given project.Manage and direct analysis of samples and timeline from preclinical and clinical studies for the project at CRO labs.Participate actively in PS subteams, act as primary contact person for DMPK project leader.Act as Bioanalytical Leader when required. Interact proactively with the assay development team.Ensure full compliance with the current global and local bioanalytical guidance and GxPs.Leadership in Bioanalysis: *remain current and continually develop expertise in bioanalytical science. Contribute to scientific consortia when required; *maintain current expertise in the validation and conduct of bioanalytical assays; *guide and manage the bioanalysis at CROs and ensure that most advanced and most efficient procedures are used.Provide technical leadership in issue resolution.Review protocols and other relevant documents and guide project teams in all aspects of bioanalytical work required for the project.Review and write reports for regulatory submissions; support filings and answer any questions about bioanalytics coming from the regulatory agencies.Maintain open links with other disciplines within the department and the organization.Advise Group Head concerning all needs relating to administrative processes, technologies and equipment. Inform him of all critical issuesMust haves:Minimum 3 years in a similar position focused on bioanalysis in pharma or CRO (pharma preferred) OR scientist focused on bioanalysisExcellent work experience on both large and small molecules bioanalysis (preferred and will receive 5 stars) IF not both, either large or smallStrong vendor management experience, looking after outsourced studies to external CROs (*****)Degree in biology/biochemistry (*****)
PhD Student 100% | befristet
Insel Gruppe, Bern
As a leading university hospital with a rich tradition, the Inselspital is part of the Insel Group and is a centre of medical expertise and high technology with an international reputation as well as being a first-class training and research centre.PhD Student Tumor Immunology LaboratoryDepartment of Medical Oncology/Department for BioMedical Research (DBMR)University of Bern, Switzerland 100 % | in Bern is looking for as soon as possible or as agreed uponlimited time for 4 years (Salary based on the regulation by the Swiss National Science Foundation) Our research group investigates the interaction of immune cells with leukemia and cancer stem cells. A special focus of our work comprises the analysis of so-called cancer stem cells (CSCs). These cells are the origin of the disease and the main reason for relapse after initial response to therapy. Aim of our research is to improve and develop immunotherapies for cancer patients. Our research makes primarily use of syngeneic tumor mouse models, cell lines and primary patient material. The position offers a brought insight into translational research starting from pre-clinical models to clinical application.The challenge We have an open position for a highly motivated PhD student in our lab. The focus of the work is the identification and validation of immune-related targets in pre-clinical settings and translate the findings towards clinical application. The aim of the projects will be to identify immune signatures of cancer stem cells in head and neck squamous cell carcinoma (HNSCC) and to define targets for immunotherapy with the potential to selectively eliminate CSCs. This pre-clincial/translational research project will provide opportunities to learn and use state-of-the-art techniques in immunology (e.g. FACS analysis), molecular biology (e.g. CRISPR and RNA sequencing) and stem cell biology (e.g. organoid cultures).Your profile The successful applicant is expected to have a Master in biological sciences or related disciplines and experience in immunological techniques (e.g. FACS, T/NK cell assays), stem cell assays (e.g. oragnoids) as well as molecular biology techniques such as qRT-PCR and next-generation RNA sequencing. Experi-ence with mouse handling and experimentation are desirable.The package Young, dynamic team and attractive, varied working conditions.Contact Prof. Adrian Ochsenbein andProf. Dr. sc. nat. Carsten Riether,Tumor Immunology Laboratory,Department for BioMedical Research (DBMR)Murtenstrasse 35, MEM D806,3010 BernYour application Please only apply online. Code number 12543The Insel Group The Insel Group forms Switzerland's largest full-service medical care system -– from primary care through to state-of-the-art medicine -– that is available to everyone in the country. This ensures that every patient is treated at the most appropriate place for them and has access to the latest technologies, methods and medical options at all times. Your place of work Inselspital, Universitätsspital BernFreiburgstrasse, CH-3010 BernSchweiz Our strengths – your benefits Top training organisation As a university hospital and the leading training institution in Canton Bern, the Inselspital offers training in 36 out of 44 possible medical disciplines. In their role as training organisations, the university clinics and institutes of the Insel Group are rated with an "A" – the highest classification.In addition, the Insel Group offers practical training and CPD (continuous professional development) for all health professions up to specialist nursing care. It offers a broad range of vocational traineeships for its trainees, who currently number 300. Fostering personal development and career paths We are keen to foster personal development among our staff. Career opportunities and relevant models are transparent; CPD is provided with generous support. Women and careers Gender equality and the advancement of women are a big priority for us. Our career paths and models are designed so that part-time work and family responsibilities are no obstacles to taking on responsibility at our company. Individual working time arrangements Flexible working hours, part-time work and job-sharing. We are keen to accommodate the needs of our staff where the role and operating requirements of the hospital allow. This also applies to our executive-grade roles. Children's day care and kindergarten We offer 115 childcare places for around 180 children up to pre-school age at various locations. At the Inselspital site, there is also a group for babies from the fourth month and a private kindergarten. Generous holiday arrangements As a family-friendly employer, the Insel Group provides generous schemes for unpaid leave, short remunerated breaks and parental leave in the event of the birth of a child or an adoption. Fathers also receive 15 working days paid paternity leave. Extra days of leave are offered by way of a loyalty bonus from as early as the fifth year of service! Attractive workplace Bern and its region assume a central role in Switzerland. With its enviable infrastructure, rapid links to the country's major conurbations, proximity to urban and rural districts and variety of wonderful recreational areas, Bern and its environs offer an unusually high quality of life. Exceptional benefits The social package we offer is far above the industry average. Our benefits are exceptional, particularly in the case of maternity leave, continued payment of salary in the event of sickness and accident, and full payment of daily sickness allowance or group health insurance premiums. Meaningful diversity and equal opportunities We provide medical excellence with a human touch and respect for one another. As a big business we create a unique family atmosphere through meaningful diversity within the Insel Group. Induction programmes For us it is very important new employees undergo a well prepared and thorough induction. We give you detailed information about your new employer at a monthly welcome event and also provide tailored induction programmes in the clinics, institutes and administrative departments. Award-winning catering Every site operated by the Insel Group has one or more staff restaurants. Our staff appreciate the quality, variety and creativity of our catering, which has repeatedly won prestigious gastronomy prizes. Innovation and research Innovations in medicine and research are only possible if we continue to develop. Rapid developments in the medical field bring about extraordinary processes of change – as well as prospects for individual development for you. Our valuesHumanityRespect and a high regard for the individual are central to everything we do.CompetenceWe have confidence in our abilitiesand share our knowledge for the benefit of all our patients.QualityOur actions comply with the highest standards of quality and safety.InnovationWe seek new approaches as well as promote research and innovation.CooperationWe treat one another with respect and appreciation, foster professional cooperation and promote interdisciplinarity.IntegrityWe are committed to our values and are guided by sincerity, transparency and dependability.Facts and figuresFacts and figures6 sites in the canton of BernOver 10,000 employees from around 80 countriesOver 300 trainees in 16 vocational fields15,185 placement/training weeks (at tertiary level, medical and other professions)Around 500,000 patients, including over 60,750 inpatients1st class: the Inselspital is the leading Swiss university hospital in terms of patient satisfaction. University hospital (highly specialist care, all disciplines) City hospital Tiefenau (comprehensive primary care and secondary care) Rural hospitals (primary care close to home) Apply
PhD Position in Nanoscience - The Swiss Nanoscience Institute (SNI)
University of Basel, Basel, CH
The Swiss Nanoscience Institute (SNI) at the University of Basel invites highly motivated scientists to apply for the SNI PhD program in Nanoscience.Your positionX-ray crystallography at cryogenic temperatures (100 K, Cryo-MX), has played an important role in the structural characterization of proteins, such as enzymes, channels and receptors. Roughly 90% of all crystal structures in the Protein Data Bank (PDB) have been recorded using deep-frozen protein crystals. Although highly successful with regard to solving structures free of radiation damage, it has gradually become clear that the protein conformations observed by Cryo- MX may not necessarily be physiologically relevant. Rapid cooling of the protein crystals can populate non-physiological conformations of proteins because enthalpically stabilized states dominate over high entropy states [1]. The rapid cooling process does not allow full equilibration, with the result that the observed structures may represent artificial conformations – neither biologically relevant nor thermodynamically favored [2]. Because polar interactions are temperature sensitive, the precise arrangements of protein residues, ligands and solvent molecules in the active sites of enzymes, channels and receptors are prone to significant change upon cryo-cooling. These changes can lead to false conclusions.This project aims to implement room temperature (RT) crystallography methods to determine enzyme structures that are physiologically more relevant that those emerging from standard measurements at cryogenic temperatures.[1] D. A. Keedy et al., "An expanded allosteric network in PTP1B by multitemperaturecrystallography, fragment screening, and covalent tethering," Elife, vol. 7, 2018.[2] M. Fischer, B. K. Shoichet, and J. S. Fraser, "One Crystal, Two Temperatures: Cryocooling Penalties Alter Ligand Binding to Transient Protein Sites," ChemBioChem, vol. 16, no. 11, pp. 1560–1564, Jul. 2015Your profileCandidates are required to have a MS degree in natural sciences, preferably with a solid background in the topics described above, as well as good English language skills. We seek a scientifically ambitious individual who enjoys working in an interdisciplinary and collaborative environment on a highly competitive subject.We offer youExcellent scientific and social environmentVery competitive employment conditionsMembership in a very supportive and recognised communityThe successful candidate will join an attractive interdisciplinary programme together with the ~30 currently supported scientists. The SNI covers a wide variety of topics, including cutting edge quantum physics and chemistry, material science, nanotechnology, biochemistry, cell biology, or medical research.Application / ContactMore information and the online application platform can be found at www.phd.nanoscience.ch. For questions please contact the head of the SNI PhD programme, Dr. Andreas Baumgartner (andreas.baumgartner@unibas.ch), or directly the respective project leaders. The complete application has to be submitted before 31 December 2021. Please note that the decision to fill a given vacancy can be taken at any time from now.
PhD position in bosonic quantum error correction with superconducting circuits (P2101)
University of Basel, Basel, CH
The Swiss Nanoscience Institute (SNI) at the University of Basel invites highly motivated scientists to apply for the SNI PhD program in Nanoscience.Your positionWe are looking for a PhD student for a joint research activity between the Quantum Technologies Group at the Paul Scherrer Institut (https://www.psi.ch/en/lmn/bosonicquantum-error-correction-with-superconducting-circuits) and the Quantum Theory Group at the University of Basel (https://quantumtheory-bruder.physik.unibas.ch/en/). The student will become member of the Swiss Nanoscience Institute (SNI) PhD school.We will develop new ways to store and manipulate quantum information in nonlinear superconducting oscillators. A key element of our work will be to make use of the many energy levels present in these oscillators to encode qubits that are intrinsically protected against errors. Part of our work will be to devise and implement new nanofabrication processes for superconducting circuits compatible with bosonic quantum error correction. Our goal is to explore both the promise of this approach for quantum computation and simulation, as well as its fundamental aspects in the context of out-of-equilibrium physics.We are looking for a motivated student with experience or interest in circuit QED, nanofabrication, and nonlinear quantum optics. Over the course of the project, she/he will acquire a wide range of experimental skills including:Cryogenics and operation of dilution refrigeratorsMicrowave circuit designNanofabrication and characterization (lithography, growth and deposition, SEM, AFM, etc.)Experimental control and data analysis softwareQuantum measurement and control techniquesIn addition, the student will participate in the theoretical developments associated with the project.Your profileCandidates are required to have a MS degree in physics/electronics/mechanics or similar, with a solid background in quantum mechanics, as well as good English language skills. Prior experience in any of the techniques mentioned above is considered a plus. We seek a scientifically ambitious individual who enjoys working in an interdisciplinary and collaborative environment on a highly competitive subject.We offer youExcellent scientific and social environmentVery competitive employment conditionsMembership in a very supportive and recognised communityThe successful candidate will join an attractive interdisciplinary programme together with the ~30 currently supported scientists. The SNI covers a wide variety of topics, including cutting edge quantum physics and chemistry, material science, nanotechnology, biochemistry, cell biology, or medical research.Application / ContactMore information and the online application platform can be found at www.phd.nanoscience.ch. For questions please contact the head of the SNI PhD programme, Dr. Andreas Baumgartner (andreas.baumgartner@unibas.ch), or directly the respective project leaders. The complete application has to be submitted before 31 December 2021. Please note that the decision to fill a given vacancy can be taken at any time from now.
PhD Position on Innovative Catalytic Strategies to Combat Cancer (P2106)
University of Basel, Basel, CH
The Swiss Nanoscience Institute (SNI) at the University of Basel invites highly motivated scientists to apply for the SNI PhD program in Nanoscience.Your positionWithin this PhD project, we aim to attach metal-containing cofactors (Mcof) to the surface of cancer cells, and to use their catalytic properties to uncage specific drugs. With this ambitious goal in mind, the Mcof will be equipped with a high-affinity antagonist that binds tightly to proteins that are overexpressed on the surface of cancer cells.To evaluate the therapeutic potential of this strategy, we have selected somatostatin, a G-coupled protein receptor that is highly present on the surface of various forms of cancer. Cyclic disulfide-bridged peptides (Cyc-peptS–S), developed in the group of Prof. Fani, display exquisite affinity and selectivity for somatostatin receptors. Upon covalent linking of the peptide with the metal cofactor to afford Cyc-peptS–S–Mcof, we anticipate that the catalytically active cofactor will accumulate in the proximity of cancer tissues that display multiple copies of the somatostatin receptor. Upon addition of a caged drug, the catalytic activity of the cofactor Cyc-peptS–S–Mcof will lead to the site-specific uncaging of the drug where its action is required (an illustration can be found in the project description at www.phd.nanoscience.ch). In the past years, the Ward group has pioneered several catalytic strategies that lead to the uncaging of various fluorescent probes and drugs in the presence of cells. Reactions include olefin metathesis, transfer-hydrogenation, allylic substitution, hydroamination reactions, etc. In the course of his/her PhD, the researcher will work in a highly stimulating environment at the interface between chemistry, biology and medicine. The work will be carried out in close collaboration between the Ward and Fani groups.Your profileCandidates are required to have an MS degree in natural sciences, and should especially have a relevant experimental background in organic synthesis as well as in any of the following: mammalian cell culture, molecular biology, flow cytometry and FACS, high-throughput experimentation.We offer youExcellent scientific and social environmentVery competitive employment conditionsMembership in a very supportive and recognised communityThe successful candidate will join an attractive interdisciplinary programme as a junior SNI member, together with the ~30 currently supported scientists, and will benefit from strong personal support, a strongly interdisciplinary social environment, and training in soft skills offered by the PhD program and the many internal SNI events. The SNI in general covers a wide variety of topics, including cutting edge quantum physics and chemistry, material science, nanotechnology, biochemistry, cell biology, or medical research.Application / ContactMore information and the online application platform can be found at www.phd.nanoscience.ch. For questions please contact the head of the SNI PhD programme, Dr. Andreas Baumgartner (andreas.baumgartner@unibas.ch), or directly the respective project leaders. The complete application has to be submitted before 31 December 2021. Please note that the decision to fill a given vacancy can be taken at any time from now.
PhD Position- Structure and Assembly Mechanism of the Ninjurin-1 Membrane Perforation Pore in Executing Cell Death
University of Basel, Basel, CH
The Swiss Nanoscience Institute (SNI) at the University of Basel invites highly motivated scientists to apply for the SNI PhD program in Nanoscience.Your positionThe rupture of the eukaryotic plasma membrane mediated by the membrane protein ninjurin-1 is the defining endpoint of multiple different types of cell death. We aim at deciphering the mechanisms of ninjurin-1 in assembling membrane rupturing pores by a unique combination of structural biology methods, nanotechnological approaches, and super-resolution light microscopy.Background: Eukaryotic cells possess remarkable control mechanisms to retain functionality during their life cycle and to ensure their proper removal in the multicellular context [1,2]. Among these mechanisms are multiple forms of cell death, most of which end with the rupture of the plasma cell membrane. So far, rupture of this membrane was generally thought to be a consequence of osmotic pressure, caused by the uncontrolled influx of water. It was recently discovered that plasma membrane rupture is an active process, mediated by the protein ninjurin-1 [3]. Ninjurin-1 is a ubiquitously expressed, 16-kDa plasma membrane protein, and conserved from fruit fly to man [4] Understanding this process at atomic level will be crucial for therapeutic intervention.The goal of this thesis: We want to determine the structure of the ninjurin-1 membrane inserted pore at atomic level and unravel its insertion mechanism in the cellular context. We aim at the atomic resolution structure of the ninjurin-1 pores by single-particle cryo-electron microscopy [5,6]. In addition, we will characterize the ninjurin-1 system by NMR spectroscopy [6]. In parallel, we will monitor ninjurin-1 oligomeric assembly and pore formation by AFM and TEM [7–10]. Time-lapse multiparametric AFM will allow us to image the pore formation process at a resolution of ≈1-2 nm and to simultaneously map how ninjurin-1 insertion and assembly alters the mechanical properties of the target membrane. Along a third line of research, we will also study the pore assembly in living cells by MinFlux microscopy, which allows an isotropic resolution of 1-5 nm of fluorophores in 3D [11,12].This project follows a long-standing and highly fruitful collaboration between the Hiller and Müller labs, combining their complementary expertise in biophysics and structural biology [7,10,13]. With the relocation of the D-BSSE to the Schellenmätteli campus in mid-2022, the two labs will be neighbours. The student will be embedded in both groups and have full infrastructure access at both departments.[1] Broz P et al. Nat Rev Immunol 20, 143–157 (2020), [2] Broz P et al. Nat Rev Immunol 16, 407–420 (2016), [3] Kayagaki N et al. Nature 591, 131–136 (2021), [4] Araki T et al. Neuron 17, 353–361 (1996), [5] Kaur H et al. Nature 593, 125–129 (2021), [6] Sborgi L et al. Proc Natl Acad Sci USA 112, 13237–13242 (2015), [7] Sborgi L et al. EMBO J 35, 1766–1778 (2016), [8] Dufrêne Y et al. Nat Methods 10, 847–854 (2013), [9] Dufrêne Y et al. Nat Nanotech 12, 295–307 (2017), [10] Mulvihill E et al. EMBO J 37, e98321 (2018), [11] Gwosch KC et al. Nat Methods 17, 217–224 (2020), [12] Schmidt R et al. Nat Commun 12, 1478 (2021), [13] Thoma J et al. Nat Struct Mol Biol 22, 795–802 (2015)Your profileCandidates are required to have a MS degree in natural sciences, preferably with a solid background in the topics described above, as well as good English language skills. We seek a scientifically ambitious individual who enjoys working in an interdisciplinary and collaborative environment on a highly competitive subject.We offer youExcellent scientific and social environmentVery competitive employment conditionsMembership in a very supportive and recognised communityThe successful candidate will join an attractive interdisciplinary programme together with the ~30 currently supported scientists. The SNI covers a wide variety of topics, including cutting edge quantum physics and chemistry, material science, nanotechnology, biochemistry, cell biology, or medical research.Application / ContactMore information and the online application platform can be found at www.phd.nanoscience.ch. For questions please contact the head of the SNI PhD programme, Dr. Andreas Baumgartner (andreas.baumgartner@unibas.ch), or directly the respective project leaders. The complete application has to be submitted before 31 December 2021. Please note that the decision to fill a given vacancy can be taken at any time from now.
Bioassay Group Head - Temporary Contract (3 years)
Roche, Basel-Stadt, Basel
Pharma Technical Development Europe Biologics brings game-changing therapies from clinical phase I into the market to serve every patient, every day. Our core business is to develop safe, innovative and effective drugs using cutting edge technologies for manufacturing process (Drug Substance and Drug Product), clinical supply, analytics, formulation, device and packaging. Our daily work includes authoring of regulatory documents and the transfer of development projects to the commercial organization.We are striving for a caring and sensing network organization, which lives a culture of trust and collaboration. Our smart people drive innovation through their expertise, passion and "getting it done" mentality. The benefit for the patient is in the centre of our thoughts and efforts.The bioassay groups as part of the department Analytical Development and Quality Control Biotech Europe are responsible for Analytical Development, Quality Control and Compliance for Biopharmaceuticals from pre Investigational New Drug (IND) to New Drug Application (NDA) and Launch.Your contribution:Evaluation, implementation, and further development of new technologies/ test methods to ensure the biological activity of our BiopharmaceuticalsQuality control for investigational medicinal products and batches used in preclinical and clinical studiesPreparation and support of IND and BLA (Biologics License Application) filings Creation of prerequisites for securing a competent, efficient GxP conform analytics in due time and keeping the current GxP guidelines as well as the relevant SOPsDirect leadership responsibility for a team of approx. 4-8 membersEstablish close and trustful collaborations and relationshipsWho you are:You are someone who wants to influence your own development. You are looking for a company where you have the opportunity to pursue your interests across functions and geographies. Where a job title is not considered the final definition of who you are, but the starting point. Additionally to that, we are looking for the following qualifications and experience: PhD in life science as Biology, Biochemistry, Pharmacy or similar scientific qualificationMin. 3-5 years of experience in biopharmaceutical industry with focus on cell based assays, preferably in a GMP environmentExperience in development of new technologies and methods for biological analysis and characterization of proteinsExcellent leadership skills and proven track record in people management and collaboration Excellent verbal and written communication skills with success in building trustful relationships Self-motivated, proactive, responsible, result-oriented and an excellent team playerGood communication and negotiation skills in German and EnglishJob Level:Team Leader
Postdoc (w/m) 80% - 100% | befristet
Insel Gruppe, Bern
As a leading university hospital with a rich tradition, the Inselspital is part of the Insel Group and is a centre of medical expertise and high technology with an international reputation as well as being a first-class training and research centre.Postdoc (w/m) Medizinbereich QuerschnittsfächerUnversity Institute of Clinical Chemistry 80 - 100 % | in Bern is looking for as soon as possible or as agreed uponlimitedThe challenge We are looking for a highly motivated postdoc in lipid metabolism and lipidomics/metabolomics to join our team at the institute of Clinical Chemistry. The project aims at understanding lipid metabolism in metabolic disorders. The team will investigate alterations in lipid metabolism and associated molecular mechanisms during disease progression in pre-clinical models and clinical studies. The team uses both computational and experimental models.Your profile The successful candidate will have a PhD/MD or equivalent in biochemistry, analytical chemistry, lipid biology or related fields with a strong background in mass spectrometry. Proficiency in mass spectrometry (both high- and low-resolution mass spec) is essential. Good knowledge of physiology and metabolism is required. The successful candidate must exhibit excellent communication skills in English, an ability to handle complex projects and a potential for excellence in research productivity through publications.The package We offer a stimulating and multidisciplinary research environment and our group works closely with Hepatology and Endocrinology clinics. The institute offers expertise in laboratory medicine, epidemiology, immunology and metabolism with the state-of-the-art platforms for biobanking, genomics, pharmacogenomics, cytomics and metabolomics.Contact If you have any further question regardingthis position please contact:Prof. Dr. phil. Mojgan Masoodi,Head of Research,Phone +41 31 664 05 32Your application Please only apply online. Code number 12910The Insel Group The Insel Group forms Switzerland's largest full-service medical care system -– from primary care through to state-of-the-art medicine -– that is available to everyone in the country. This ensures that every patient is treated at the most appropriate place for them and has access to the latest technologies, methods and medical options at all times. Your place of work Inselspital, Universitätsspital BernFreiburgstrasse, CH-3010 BernSchweiz Our strengths – your benefits Top training organisation As a university hospital and the leading training institution in Canton Bern, the Inselspital offers training in 36 out of 44 possible medical disciplines. In their role as training organisations, the university clinics and institutes of the Insel Group are rated with an "A" – the highest classification.In addition, the Insel Group offers practical training and CPD (continuous professional development) for all health professions up to specialist nursing care. It offers a broad range of vocational traineeships for its trainees, who currently number 300. Fostering personal development and career paths We are keen to foster personal development among our staff. Career opportunities and relevant models are transparent; CPD is provided with generous support. Women and careers Gender equality and the advancement of women are a big priority for us. Our career paths and models are designed so that part-time work and family responsibilities are no obstacles to taking on responsibility at our company. Individual working time arrangements Flexible working hours, part-time work and job-sharing. We are keen to accommodate the needs of our staff where the role and operating requirements of the hospital allow. This also applies to our executive-grade roles. Children's day care and kindergarten We offer 115 childcare places for around 180 children up to pre-school age at various locations. At the Inselspital site, there is also a group for babies from the fourth month and a private kindergarten. Generous holiday arrangements As a family-friendly employer, the Insel Group provides generous schemes for unpaid leave, short remunerated breaks and parental leave in the event of the birth of a child or an adoption. Fathers also receive 15 working days paid paternity leave. Extra days of leave are offered by way of a loyalty bonus from as early as the fifth year of service! Attractive workplace Bern and its region assume a central role in Switzerland. With its enviable infrastructure, rapid links to the country's major conurbations, proximity to urban and rural districts and variety of wonderful recreational areas, Bern and its environs offer an unusually high quality of life. Exceptional benefits The social package we offer is far above the industry average. Our benefits are exceptional, particularly in the case of maternity leave, continued payment of salary in the event of sickness and accident, and full payment of daily sickness allowance or group health insurance premiums. Meaningful diversity and equal opportunities We provide medical excellence with a human touch and respect for one another. As a big business we create a unique family atmosphere through meaningful diversity within the Insel Group. Induction programmes For us it is very important new employees undergo a well prepared and thorough induction. We give you detailed information about your new employer at a monthly welcome event and also provide tailored induction programmes in the clinics, institutes and administrative departments. Award-winning catering Every site operated by the Insel Group has one or more staff restaurants. Our staff appreciate the quality, variety and creativity of our catering, which has repeatedly won prestigious gastronomy prizes. Innovation and research Innovations in medicine and research are only possible if we continue to develop. Rapid developments in the medical field bring about extraordinary processes of change – as well as prospects for individual development for you. Our valuesHumanityRespect and a high regard for the individual are central to everything we do.CompetenceWe have confidence in our abilitiesand share our knowledge for the benefit of all our patients.QualityOur actions comply with the highest standards of quality and safety.InnovationWe seek new approaches as well as promote research and innovation.CooperationWe treat one another with respect and appreciation, foster professional cooperation and promote interdisciplinarity.IntegrityWe are committed to our values and are guided by sincerity, transparency and dependability.Facts and figuresFacts and figures6 sites in the canton of BernOver 10,000 employees from around 80 countriesOver 300 trainees in 16 vocational fields15,185 placement/training weeks (at tertiary level, medical and other professions)Around 500,000 patients, including over 60,750 inpatients1st class: the Inselspital is the leading Swiss university hospital in terms of patient satisfaction. University hospital (highly specialist care, all disciplines) City hospital Tiefenau (comprehensive primary care and secondary care) Rural hospitals (primary care close to home) Apply